ARVIND.NS(ARVIND.NS)
ARVIND.NS
No analyst ratings available
No analyst price targets available for ARVIND.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $112.73B | $125.72B | $144.67B | $150.26B |
| Low | $109.98B | $114.12B | $136.01B | $141.26B |
| High | $115.91B | $133.32B | $151.19B | $157.03B |
| EBITDA Avg | $12.95B | $14.44B | $16.62B | $17.26B |
| Low | $12.63B | $13.11B | $15.62B | $16.23B |
| High | $13.31B | $15.31B | $17.37B | $18.04B |
| EBIT Avg | $9.30B | $10.37B | $11.93B | $12.39B |
| Low | $9.07B | $9.41B | $11.22B | $11.65B |
| High | $9.56B | $10.99B | $12.47B | $12.95B |
| Net Income Avg | $5.88B | $7.24B | $9.37B | $11.82B |
| Low | $5.55B | $6.54B | $8.64B | $10.90B |
| High | $6.44B | $8.03B | $9.92B | $12.52B |
| EPS Avg | $22.44 | $27.61 | $35.73 | $45.10 |
| Low | $21.16 | $24.94 | $32.95 | $41.59 |
| High | $24.56 | $30.61 | $37.83 | $47.74 |
| Analysts (Rev / EPS) | 7 / 7 | 8 / 8 | 4 / 3 | 4 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $28.79B | $29.22B | $32.31B |
| Low | $28.79B | $29.22B | $32.31B |
| High | $28.79B | $29.22B | $32.31B |
| EBITDA Avg | $3.31B | $3.36B | $3.71B |
| Low | $3.31B | $3.36B | $3.71B |
| High | $3.31B | $3.36B | $3.71B |
| EBIT Avg | $2.37B | $2.41B | $2.66B |
| Low | $2.37B | $2.41B | $2.66B |
| High | $2.37B | $2.41B | $2.66B |
| Net Income Avg | $1.44B | $1.54B | $1.91B |
| Low | $1.44B | $1.54B | $1.91B |
| High | $1.44B | $1.54B | $1.91B |
| EPS Avg | $5.50 | $5.90 | $7.30 |
| Low | $5.50 | $5.90 | $7.30 |
| High | $5.50 | $5.90 | $7.30 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |